China Resources Medical Holdings Company Limited

SEHK:1515 株式レポート

時価総額:HK$5.3b

China Resources Medical Holdings 将来の成長

Future 基準チェック /36

China Resources Medical Holdings利益と収益がそれぞれ年間31.9%と5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に12% 31.9%なると予測されています。

主要情報

31.9%

収益成長率

31.9%

EPS成長率

Healthcare 収益成長19.3%
収益成長率5.0%
将来の株主資本利益率12.0%
アナリストカバレッジ

Good

最終更新日26 Dec 2024

今後の成長に関する最新情報

Recent updates

Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Nov 14
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down

Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

Oct 02
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Apr 26
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Mar 09
Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

Nov 29
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Oct 19
China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Aug 30
Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

Aug 26
Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Jun 30
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

May 12
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Apr 03
Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Feb 21
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

Jan 10
China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Nov 30
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

Oct 18
Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Sep 21
China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Jul 13
Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Jun 24
Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

Jun 03
China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

Apr 27
China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Apr 22
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Mar 30
Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

Jan 27
Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 03
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Nov 19
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Oct 26
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Sep 20
An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

Sep 06
Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Aug 17
China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Jun 21
Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Jun 09
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

May 03
Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Apr 22
China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

Mar 27
We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

業績と収益の成長予測

SEHK:1515 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202611,341886N/A1,3874
12/31/202510,9087921,2131,5116
12/31/202410,4217119841,2356
6/30/20249,9702946211,162N/A
3/31/202410,0392766651,179N/A
12/31/202310,1082587081,195N/A
9/30/20239,9583387321,251N/A
6/30/20239,8094197561,307N/A
3/31/20238,8553425771,086N/A
12/31/20227,901266397864N/A
9/30/20226,891365422772N/A
6/30/20225,881463447680N/A
3/31/20225,164441479695N/A
12/31/20214,447418512710N/A
9/30/20214,031410392628N/A
6/30/20213,615402271546N/A
3/31/20213,183356349595N/A
12/31/20202,751310426644N/A
9/30/20202,404313483614N/A
6/30/20202,058315540584N/A
3/31/20202,087353435475N/A
12/31/20192,115391330366N/A
9/30/20192,112401263300N/A
6/30/20192,108412196234N/A
3/31/20192,084421236284N/A
12/31/20182,059431277334N/A
9/30/20181,996364317371N/A
6/30/20181,932298357407N/A
3/31/20181,905360N/A433N/A
12/31/20171,878421N/A460N/A
9/30/20171,784-446N/A377N/A
6/30/20171,690-1,312N/A294N/A
3/31/20171,611-1,410N/A259N/A
12/31/20161,533-1,507N/A224N/A
9/30/20161,504-656N/A227N/A
6/30/20161,475196N/A230N/A
3/31/20161,424181N/A231N/A
12/31/20151,372167N/A232N/A
9/30/20151,337208N/A246N/A
6/30/20151,302249N/A261N/A
3/31/20151,254240N/A268N/A
12/31/20141,206230N/A274N/A
9/30/20141,090176N/A238N/A
6/30/2014975122N/A202N/A
3/31/2014931106N/A186N/A
12/31/201388790N/A170N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1515の予測収益成長率 (年間31.9% ) は 貯蓄率 ( 2.3% ) を上回っています。

収益対市場: 1515の収益 ( 31.9% ) はHong Kong市場 ( 11.5% ) よりも速いペースで成長すると予測されています。

高成長収益: 1515の収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: 1515の収益 ( 5% ) Hong Kong市場 ( 7.8% ) よりも低い成長が予測されています。

高い収益成長: 1515の収益 ( 5% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 1515の 自己資本利益率 は、3年後には低くなると予測されています ( 12 %)。


成長企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2024/12/28 03:15
終値2024/12/27 00:00
収益2024/06/30
年間収益2023/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

China Resources Medical Holdings Company Limited 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。27

アナリスト機関
Ling ZhangBNP Paribas Securities (Asia)
Yue-Kwong LuiBOCOM International Securities Limited
Jessica LiBofA Global Research